Cardiometabolic and Muscular Fatigue Responses to Different CrossFit® Workouts.

CrossFit® consists of workouts of the day (WODs) in which different exercises are conducted at high intensity with minimal or no rest periods. This study sought to quantify exercise intensity and muscular fatigue in the three CrossFit® session modalities: gymnastics (G), metabolic conditioning (M) and weightlifting (W). Thirty two, young, strength-trained, healthy men completed the three WODs: G ("Cindy"), M (double skip rope jumps) and W (power cleans). The variables measured in the sessions were: mean heart rate (HR), rate of perceived exertion (RPE), blood lactate [lactate], and jump height (H), average power (AP) and maximum take-off velocity (Vmax) in a counter movement jump test. In all three WODs, elevated HR values (≥90% of the theoretical HRmax) were recorded at the time points mid-session and end-session. Mean RPEs were 17.6 ± 1.6 (G WOD), 16.0 ± 2.3 (M WOD), and 15.7 ± 2.0 (W WOD). Postexercise [lactate] was higher than 10 mmol·L-1 for the three WODs. Following the G ("Cindy") and W (power cleans) WODs, respectively, significant muscular power losses were observed in H (7.3% and 8.1%), Vmax (13.8% and 3.3%), AP relative (4.6% and 8.3%) and AP total (4.2% and 8.2%) while losses in the M WOD were not significant (p > 0.05). A vigorous intensity of exercise was noted in all three WODs, with greater mean HRs detected in the "Cindy" and skip rope WODs than power clean WOD. Muscular fatigue was produced in response to the "Cindy" and power clean WODs but not the skip rope WOD.

Effects of ß-alanine supplementation during a 5-week strength training program: a randomized, controlled study.

BACKGROUND: ß-Alanine (BA) is a non-essential amino acid that has been shown to enhance exercise performance. The purpose of this investigation was to determine if BA supplementation improved the adaptive response to five weeks of a resistance training program. METHODS: Thirty healthy, strength-trained individuals were randomly assigned to the experimental groups placebo (PLA) or BA. Over 5 weeks of strength training, subjects in BA took 6.4 g/day of BA as 8 × 800 mg doses each at least 1.5 h apart. The training program consisted of 3 sessions per week in which three different leg exercises were conducted as a circuit (back squat, barbell step ups and loaded jumping lunges). The program started with 3 sets of 40 s of work per exercise and rest periods between sets of 120 s in the first week. This training volume was then gradually built up to 5 sets of 20 s work/60 s rest in the fifth week. The work load during the program was set by one of the authors according to the individual's perceived effort the previous week. The variables measured were average velocity, peak velocity, average power, peak power, and load in kg in a back squat, incremental load, one-repetition maximum (1RM) test. In addition, during the rest period, jump ability (jump height and power) was assessed on a force platform. To compare data, a general linear model with repeated measures two-way analysis of variance was used. RESULTS: Significantly greater training improvements were observed in the BA group versus PLA group (p = 0.045) in the variables average power at 1RM (BA: 42.65%, 95% CI, 432.33, 522.52 VS. PLA: 21.07%, 95% CI, 384.77, 482.19) and average power at maximum power output (p = 0.037) (BA: 20.17%, 95% CI, 637.82, 751.90 VS. PLA; 10.74%, 95% CI, 628.31, 751.53). The pre- to post training average power gain produced at 1RM in BA could be explained by a greater maximal strength gain, or load lifted at 1RM (p = 0.014) (24 kg, 95% CI, 19.45, 28.41 VS. 16 kg, 95% CI, 10.58, 20.25) and in the number of sets executed (p = 0.025) in the incremental load test (BA: 2.79 sets, 95% CI, 2.08, 3.49 VS. PLA: 1.58 sets, 95% CI, 0.82, 2.34). CONCLUSIONS: ß-Alanine supplementation was effective at increasing power output when lifting loads equivalent to the individual's maximal strength or when working at maximum power output. The improvement observed at 1RM was explained by a greater load lifted, or strength gain, in response to training in the participants who took this supplement.

Muscular fatigue in response to different modalities of CrossFit sessions.

BACKGROUND: CrossFit is a new strength and conditioning regimen involving short intense daily workouts called workouts of the day (WOD). This study assesses muscular fatigue levels induced by the three modalities of CrossFit WOD; gymnastics (G), metabolic conditioning (M) and weightlifting (W). MATERIAL AND METHODS: 34 healthy subjects undertook three WOD (one per week): a G WOD consisting of completing the highest number of sets of 5 pull-ups, 10 push-ups and 15 air squats in 20 min; an M WOD, in which the maximum number of double skipping rope jumps was executed in 8 sets (20 s), resting (10 s) between sets; and finally, a W WOD in which the maximum number of power cleans was executed in 5 min, lifting a load equivalent to 40% of the individual's 1RM. Before and after each WOD, blood lactate concentrations were measured. Also, before, during, and after each WOD, muscular fatigue was assessed in a countermovement jump test (CMJ). RESULTS: Significant reductions were produced in the mechanical variables jump height, average power and maximum velocity in response to G; and in jump height, mean and peak power, maximum velocity and maximum force in response to W (P<0.01). However, in M, significant reductions in mechanical variables were observed between pre- and mid session (after sets 2, 4, 6 and 8), but not between pre- and post session. CONCLUSIONS: Muscular fatigue, reflected by reduced CMJ variables, was produced following the G and W sessions, while recovery of this fatigue was observed at the end of M, likely attributable to rest intervals allowing for the recovery of phosphocreatine stores. Our findings also suggest that the high intensity and volume of exercise in G and W WODs could lead to reduced muscular-tendon stiffness causing a loss of jump ability, related here to a longer isometric phase during the CMJ.

The lactate and ventilatory thresholds in resistance training.

PURPOSE: This study was designed to identify the lactate threshold (LT) and first ventilatory threshold (VT1 ) in a graded resistance half-squat test and determine whether both thresholds are produced at the same workload. A further goal was to compare the visual inspection and algorithm adjustment methods of detecting both thresholds during graded resistance exercise. METHODS: Twenty-four young men completed two test sessions 48 h apart; (i) the one-repetition maximum (1RM) was determined, (ii) an incremental load test was performed to locate LT and VT1 . VT1 was calculated in three different ways based on pulmonary ventilation, the ventilatory equivalent of oxygen or the end-tidal oxygen pressure (as VT1 -VE, VT1 -VE·VO2-1 or VT1 -PetO2, respectively). RESULTS: LT and VT1 were located at the same intensity of exercise during the incremental load test. Using the algorithm method, the LT and VT1 -VE were estimated at 24·8 ± 4·8% 1RM (50·6 ± 10·5 kg) and 23·7 ± 4·8% 1RM (48·4 ± 10·0 kg), respectively; the difference between the two values being non-significant (P = 0·127). In addition, positive correlation was observed between the two thresholds (r = 0·761; P<0·001; intraclass correlation coefficient (ICC) (0·864). The visual inspection and algorithm adjustment methods provided similar LT and VT1 values (r > 0·796; ICC > 0·885). CONCLUSIONS: The LT and VT1 were readily located during the incremental load half-squat test at similar workloads using both the visual inspection and algorithm adjustment methods. Both thresholds served to define two physiological stages (I, II) corresponding to the zones described for endurance exercise. Thus, both LT and VT1 could be used to prescribe the same intensity of resistance half-squat exercise.

Efectos de la suplementación con ß-alanina sobre el rendimiento deportivo / Effects of B-alanine supplementation on Athletic performance

La carnosina, dipéptido formado por los aminoácidos ß-alanina y L-histidina, tiene importantes funciones fisiológicas entre las que destaca su función antioxidante y las relacionadas con la memoria y el aprendizaje. Sin embargo, en relación con el ejercicio, las funciones más importantes serían las relacionadas con la contractilidad muscular, al mejorar la sensibilidad al calcio en las fibras musculares, y la función reguladora del pH. De este modo, se ha propuesto que la carnosina es el principal tampón intracelular, pudiendo llegar a contribuir hasta un 7-10% en la capacidad buffer o tampón. Dado que la síntesis de carnosina parece estar limitada por la disponibilidad de ß-alanina, la suplementación con este compuesto ha ido ganando cada vez más popularidad entre la población deportista. Por ello, el objetivo del presente estudio de revisión bibliográfica ha sido el de estudiar todos aquellos trabajos de investigación que han comprobado el efecto de la suplementación con ß-alanina sobre el rendimiento deportivo. Por otra parte, también, se ha intentado establecer una posología específica que, maximizando los posibles efectos beneficiosos, reduzca al mínimo la parestesia, el principal efecto secundario presentado como respuesta a la suplementación (AU)

Carnosine, dipeptide formed by amino acids ß-alanine and L-histidine, has important physiological functions among which its antioxidant and related memory and learning. However, in connection with the exercise, the most important functions would be associated with muscle contractility, improving calcium sensitivity in muscle fibers, and the regulatory function of pH. Thus, it is proposed that carnosine is the major intracellular buffer, but could contribute to 7-10% in buffer or buffer capacity. Since carnosine synthesis seems to be limited by the availability of ß-alanine supplementation with this compound has been gaining increasing popularity among the athlete population. Therefore, the objective of this study literature review was to examine all those research works have shown the effect of ß-alanine supplementation on athletic performance. Moreover, it also has attempted to establish a specific dosage that maximizing the potential benefits, minimize paresthesia, the main side effect presented in response to supplementation (AU)